Dr. Matthew Frigault, MD
Claim this profileMassachusetts General Hospital Cancer Center
Studies Lymphoma
Studies Diffuse Large B-Cell Lymphoma
13 reported clinical trials
19 drugs studied
Area of expertise
1Lymphoma
complex cytogenetic abnormalities positive
17p deletion positive
TP53 positive
2Diffuse Large B-Cell Lymphoma
MYC positive
BCL2 positive
BCL6 positive
Affiliated Hospitals
Clinical Trials Matthew Frigault, MD is currently running
CAR T-cell Therapy
for Non-Hodgkin Lymphoma
This research study involves the study of CD79b-19 CAR T cells for treating people with relapsed/refractory Non-Hodgkin Lymphoma and to understand the side effects when treated with CD79b-19 CAR T cells. This research study involves the study drugs: * CD79b-19 CAR T cells * Fludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part of lymphodepleting process
Recruiting1 award Phase 123 criteria
Emapalumab
for Non-Hodgkin's Lymphoma
This research study involves assessing the impact of emapalumab as preventative management of CAR-T related cytokine release syndrome in participants with Non-Hodgkin's lymphoma (NHL). The research study involves the following study interventions: * Fludarabine and cyclophosphamide (Lymphodepleting Chemotherapy) * Axicabtagene Ciloleucel * Emapalumab
Recruiting1 award Phase 25 criteria
More about Matthew Frigault, MD
Clinical Trial Related2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Matthew Frigault, MD has experience with
- Fludarabine
- Cyclophosphamide
- Tisagenlecleucel
- Emapalumab
- TriPRIL CAR T Cells
- CD79b-19 CAR T Cells
Breakdown of trials Matthew Frigault, MD has run
Lymphoma
Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Mixed-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Frigault, MD specialize in?
Matthew Frigault, MD focuses on Lymphoma and Diffuse Large B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved complex cytogenetic abnormalities positive patients, or patients who are 17p deletion positive.
Is Matthew Frigault, MD currently recruiting for clinical trials?
Yes, Matthew Frigault, MD is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Matthew Frigault, MD has studied deeply?
Yes, Matthew Frigault, MD has studied treatments such as Fludarabine, Cyclophosphamide, Tisagenlecleucel.
What is the best way to schedule an appointment with Matthew Frigault, MD?
Apply for one of the trials that Matthew Frigault, MD is conducting.
What is the office address of Matthew Frigault, MD?
The office of Matthew Frigault, MD is located at: Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.